U.S. scientists are leading the first international gene search for typical ALS -- amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.
Although it's the more common form of the disease, sporadic ALS -- affecting about 90 percent of those living with the fatal neurodegenerative illness -- has been the one less studied, simply because, unlike familial ALS, no genes have been determined involved.
This week, however Dr. Bryan Traynor and John Hardy of the Packard Center for ALS Research at Johns Hopkins University are beginning the first in-depth screening for genes that underlie the "spontaneous" illness, which, as all ALS, destroys the motor neurons that enable movement, including breathing. Half of the study focuses on Italian populations.
"In the forest of exciting research that's going on in ALS," said Packard Director Jeffrey Rothstein, "this is a tall tree. We've been waiting some time for this one."
Traynor said the work will clarify the role of genes in sporadic ALS. He added: "We don't know, for example, if (sporadic) ALS is triggered by a handful of interacting genes or genes plus environment or environment alone. The study aims to clarify that."
Copyright 2006 by United Press International
Related stories:
The brightest, sharpest, fastest X-ray holograms yet
The pinhole camera, a technique known since ancient times, has inspired a futuristic technology for lensless, three-dimensional imaging. Working at both the Advanced Light Source (ALS) at the U.S. Department of Energy's Lawrence Berkeley National Laboratory, and at FLASH, the free-electron laser in Hamburg, Germany, an international group of scientists has produced two of the brightest, sharpest x-ray holograms of microscopic objects ever made, thousands of times more efficiently than previous x-ray-holographic methods.
Neurons created from skin cells of elderly ALS patients
Less than 27 months after announcing that he had institutional permission to attempt the creation of patient and disease-specific stem cell lines, Harvard Stem Cell Institute (HSCI) Principal Faculty member Kevin Eggan today proclaimed the effort a success - though politically imposed restrictions and scientific advances prompted him to use a different technique than originally planned.
New study of gene evolution could lead to better understanding of neurodegenerative disease
Genetic evolution is strongly shaped by genes' efforts to prevent or tolerate errors in the production of proteins, scientists at The University of Texas at Austin and Harvard University have found.
Various species' genes evolve to minimize protein production errors
Scientists at Harvard University and the University of Texas at Austin have found that genetic evolution is strongly shaped by genes' efforts to prevent or tolerate errors in protein production.
On the evolutionary trail of molecules that cause Lou Gehrig's disease
What became a scientific quest for Dr. Hugo Bellen and his colleagues at Baylor College of Medicine in Houston began with trying to define the function of a protein that plays a role in the nervous system.
Researchers block transmission of malaria in animal tests
By disrupting the potassium channel of the malaria parasite, a team of researchers has been able to prevent new malaria parasites from forming in mosquitoes and has thereby broken the cycle of infection during recent animal tests.
Finding clues for nerve cell repair
A new study at the Montreal Neurological Institute at McGill University identifies a key mechanism for the normal development of motor nerve cells (motor neurons) - cells that control muscles. This finding is crucial to understanding and treating a range of conditions involving nerve cell loss or damage, from spinal cord injury to neurodegenerative diseases such as ALS, also known as Lou Gehrig's disease.
Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer’s disease, Huntington’s disease, epilepsy, stroke, dementia and malignant gliomas.